Showing results (31-40 of 537) with videos related to
Sort By:
Pageof 54
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemiaS Amadori, W Arcese, G Isacchi, et al.Leukemia & Lymphoma|February 26, 1999
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative GroupsF Giona, L Annino, A M Testi, et al.Blood|August 1, 1997
Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion geneG Meloni, D Diverio, M Vignetti, et al.British Journal of Haematology|October 1, 1983
E-rosette positive acute lymphoblastic leukaemia in adolescents and adultsM Baccarani, S Amadori, R Willemze, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonographyC Cartoni, F Dragoni, A Micozzi, et al.Bone Marrow Transplantation|October 1, 1990
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autograftingP De Fabritiis, A Sandrelli, G Meloni, et al.Haematologica|May 1, 1990
High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemiaR Latagliata, M C Petti, M A Spiriti, et al.The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2 therapy in relapsed acute myelogenous leukemiaG Meloni, M Vignetti, E Pogliani, et al.Journal of Internal Medicine. Supplement|January 1, 1997
New strategies for the treatment of acute promyelocytic leukaemiaF MandelliBone Marrow Transplantation|December 7, 2000
High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility studyG Meloni, S Capria, S Trasarti, et al.Pageof 54